Pharmacology
-
Vanderbilt researchers discover new spontaneous signaling pathway in the brain
The brain is constantly firing and controlling purposeful action potentials—electronic messages used by neurons to communicate with each other and allow the brain to function. Conversely, the way spontaneous neural communication happens in the brain has been found to make use of a different process. Ege Kavalali, William Stokes Chair in Experimental… Read MoreFeb. 14, 2022
-
Ege Kavalali to lead pharmacology department in School of Medicine Basic Sciences
Ege T. Kavalali, William Stokes Professor of Experimental Therapeutics, has been named chair of the Department of Pharmacology in Vanderbilt University School of Medicine Basic Sciences. National leaders in pharmacology, members of the pharmacology department at Vanderbilt and Lawrence J. Marnett, dean… Read MoreFeb. 4, 2022
-
New target identified for rapid antidepressant drugs
THE IDEA Vanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects. This represents a new target for drug development that could fill a major gap in care for depression. Ege Kavalali (Vanderbilt University) Lisa Monteggia (John Russell/Vanderbilt University) The research was led by… Read MoreNov. 10, 2021
-
Jeffrey Conn, founding director of Warren Center for Neuroscience Drug Discovery, named 2021 fellow of American Society for Pharmacology and Experimental Therapeutics
Jeffrey Conn, Lee E. Limbird Chair and professor of pharmacology, is among 16 scientists named 2021 fellows of the American Society for Pharmacology and Experimental Therapeutics. Selection as a fellow of ASPET is an honor bestowed on members who have demonstrated excellence… Read MoreSep. 27, 2021